卡纳图(Canatu)将CNT反应堆许可给韩国FST, 用于制造芯片, 标志着碳纳米管技术商业化的关键一步。 Canatu licenses its CNT reactor to South Korea’s FST for chip-making pellicles, marking a key step in commercializing carbon nanotube tech.

卡纳图已授予韩国FINE SEMITECH公司商业许可证,允许使用其CNT100 SEMI反应堆进行大规模生产的碳纳米管纳米膜,这对先进的芯片制造至关重要。 Canatu has granted South Korea’s FINE SEMITECH CORPORATION a commercial license to use its CNT100 SEMI reactor for mass-producing carbon nanotube pellicle membranes, crucial for advanced chip manufacturing. 该反应堆于2024年9月发运,并于2025年7月获得批准,使FST能够开始生产。 The reactor, shipped in September 2024 and approved in July 2025, enables FST to begin production. Canatu在100万至500万欧元幅度的下半年领取一次性许可证费,收入在2025年第4季度确认。 Canatu received a one-time license fee in the lower half of the 1–5 million euro range, with revenue recognized in Q4 2025. 未来收入可能来自销售FST销售的专有消耗品和ellilecle的特许权使用费,尽管这些收入取决于FST的成功。 Future income may come from sales of proprietary consumables and royalties on pellicles sold by FST, though these depend on FST’s success. 这一里程碑突出显示了对CNT螺旋藻技术日益增长的市场需求。 The milestone underscores growing market demand for CNT pellicle technology.